Headache Sciences Inc.
Headache Sciences Inc. is a clinical artificial intelligence company pioneering the diagnosis and monitoring of headache disorders, with a primary focus on migraine. Leveraging advanced EEG (electroencephalography) technology and machine learning, the company has developed the world's first objective test for migraine, aiming to address the global challenge of underdiagnosis and misdiagnosis. Their mission is to provide practitioners with innovative tools to improve diagnostics, monitoring, and treatment of headache-related neurogenic and neurodegenerative disorders. With a vision of translating brain electrical activity into a comprehensive suite of diagnostic and monitoring services, Headache Sciences Inc. stands at the forefront of Software as a Medical Device (SaMD) innovation, offering hope through discovery.
What We Do
A non-invasive, affordable, and accurate test for diagnosing migraine using EEG signals and machine learning algorithms. The test achieves 92% accuracy for migraine with aura and 82% for migraine without aura, performed on non-pain days. It is currently available as an experimental consultative report.
World’s first 3D brain movie visualizing a migraine attack in real-time, created using source localization technology and EEG data, illustrating the complexity of brain signals during migraine.
Provides practitioners with tools to improve the diagnostics, monitoring, and treatment of headache-related neurogenic and neurodegenerative disorders, starting with migraine. Services include EEG-based analysis and reporting, with training for practitioners on interpreting results.
Application Area
Psychological and Cognitive Health and Performance
Digital Health Technologies
Show More (4)Key People
Dr. Alexia Cid
Medical Laboratory Technologist
News & Updates
First company to win all stages of the Norman Esch Engineering Innovation & Entrepreneurship Awards back-to-back.
Received the Founder's Fellowship Award for innovation and entrepreneurship.
Awarded to students at Ryerson University for a clear plan of product testing with intentions to learn and iterate.
Peer-reviewed publication demonstrating proof of concept for the migraine diagnostic system using machine learning and EEG.
Publication presenting advances in EEG-based migraine classification.
A second super angel investor joined Headache Sciences Inc. in 2024, supporting the company's mission.